Concepedia
Statistics
Publications
7
Citations
169
H-Index
Active since
2019
Affiliations
Tohoku University(Current)
Tohoku Medical Megabank Organization
Genesis Medical Center
Heron Therapeutics (United States)
IDEXX Laboratories (France)
Harit Panda is an author at Tohoku University specializing in nrf2 pathway activation, innate immunity, and nrf2 signaling pathway.
Publications per year
2019–2025
Microenvironmental Activation of Nrf2 Restricts the Progression of Nrf2-Activated Malignant Tumors
Makiko Hayashi, Ayumi Kuga, Mikiko Suzuki et al. · Cancer Research · 2020 · 56 citations · Full text
Medicine, Cancer Biology, Oncology +16
The <i>β</i> -TrCP-Mediated Pathway Cooperates with the Keap1-Mediated Pathway in Nrf2 Degradation <i>In Vivo</i>
Ayumi Kuga, Kouhei Tsuchida, Harit Panda et al. · Molecular and Cellular Biology · 2022 · 32 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +14
Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice
Nadine Keleku-Lukwete, Mikiko Suzuki, Harit Panda et al. · Blood Advances · 2019 · 25 citations · Full text
Life Sciences, Cell Biology, Hematology +17
Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity
Harit Panda, Mikiko Suzuki, Mitsuru Naito et al. · Free Radical Biology and Medicine · 2022 · 23 citations
Medicine, Oncology, Pharmacology +16
Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue
Nilotpal Roy, Tine Wyseure, I‐Chung Lo et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2024 · 12 citations · Full text
Medicine, Molecular Biology, Oncology +13
1–5 of 7